Sartorius AG (SOAGY)
56.63
-0.93
(-1.61%)
USD |
OTCM |
Oct 12, 16:00
Sartorius Cash from Investing (Quarterly) : -175.22M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -175.22M |
| March 31, 2026 | -92.42M |
| December 31, 2025 | -150.85M |
| September 30, 2025 | -247.95M |
| June 30, 2025 | -98.75M |
| March 31, 2025 | -84.20M |
| December 31, 2024 | -99.13M |
| September 30, 2024 | -96.10M |
| June 30, 2024 | -121.67M |
| March 31, 2024 | 712.42M |
| December 31, 2023 | -99.46M |
| September 30, 2023 | -2.573B |
| June 30, 2023 | -209.18M |
| March 31, 2023 | -241.73M |
| December 31, 2022 | -261.24M |
| September 30, 2022 | -630.49M |
| June 30, 2022 | -140.88M |
| March 31, 2022 | -189.03M |
| December 31, 2021 | -201.18M |
| September 30, 2021 | -281.02M |
| June 30, 2021 | -83.51M |
| March 31, 2021 | -109.01M |
| December 31, 2020 | -470.93M |
| September 30, 2020 | -86.44M |
| June 30, 2020 | -882.05M |
| Date | Value |
|---|---|
| March 31, 2020 | -50.79M |
| December 31, 2019 | -108.58M |
| September 30, 2019 | -67.63M |
| June 30, 2019 | -68.57M |
| March 31, 2019 | -62.45M |
| December 31, 2018 | -106.26M |
| September 30, 2018 | -62.26M |
| June 30, 2018 | -68.58M |
| March 31, 2018 | -49.90M |
| December 31, 2017 | -77.95M |
| September 30, 2017 | -80.17M |
| June 30, 2017 | -113.72M |
| March 31, 2017 | -356.09M |
| December 31, 2016 | -43.50M |
| September 30, 2016 | -89.69M |
| June 30, 2016 | -130.86M |
| March 31, 2016 | -33.96M |
| December 31, 2015 | -49.21M |
| September 30, 2015 | -54.65M |
| June 30, 2015 | -56.51M |
| March 31, 2015 | 58.39M |
| December 31, 2014 | -43.09M |
| September 30, 2014 | -23.80M |
| June 30, 2014 | -22.67M |
| March 31, 2014 | -25.61M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Mesa Laboratories, Inc. | -0.559M |
| Austar Lifesciences Ltd. | -- |
| SCHOTT Pharma AG & Co. KGaA | -56.48M |
| Agilent Technologies, Inc. | -1.032B |
| Bio-Rad Laboratories, Inc. | -66.70M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 182.17M |
| Cash from Financing (Quarterly) | -340.21M |
| Free Cash Flow | 321.06M |
| Free Cash Flow Per Share (Quarterly) | 0.2453 |
| Free Cash Flow to Equity (Quarterly) | 407.44M |
| Free Cash Flow to Firm (Quarterly) | 128.67M |
| Free Cash Flow Yield | 1.64% |